Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaToripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 120
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07358689 - 2. fázisTaking peopleA Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 28
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07091305 - 1/2. fázisTaking peopleDual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Beijing Biotech
See details and how to joinNCT07641023 - 1/2. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 178
- Run by
- Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT07610798 - 1. fázisTaking peopleA Study of HDM2020 in Patients With Advanced Sq-NSCLC
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 150
- Run by
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07638891 - 2. fázisTaking peopleEGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 32
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07637448 - 2. fázisTaking peopleMaintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 30
- Run by
- Guangzhou Institute of Respiratory Disease
See details and how to joinNCT06497530 - 2. fázisNot yet taking people in KínaA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
- Where
- Beijing, Harbin
- Életkor
- 18 év to 80 év
- People
- 227
- Run by
- GV20 Therapeutics
See details and how to joinNCT07623642 - 2. fázisNot yet taking people in KínaTrastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT07630077 - 2. fázisTaking peopleA Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07269782 - 1. fázisTaking peopleSafety and Preliminary Activity of BI115 in Advanced SCLC
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 150
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07559019 - No phaseTaking peopleAssociation Between Screening Behaviors and Lung Cancer Spectrum
- Where
- Shanghai
- People
- 5390
- Run by
- Fudan University
See details and how to joinNCT07626177 - No phaseTaking peopleEvaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 300
- Run by
- Wen-zhao ZHONG
See details and how to joinNCT07626736 - 2. fázisNot yet taking people in KínaBecotatug Vedotin Combined With Pucotenlimab ± Radiotherapy as First-Line Treatment for Driver-Gene-Negative, EGFR-Expression-Positive Advanced Non-Small Cell Lung Cancer
- Where
- Hefei
- Életkor
- 18 év to 75 év
- People
- 39
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT07627321 - No phaseTaking peopleMechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
- Where
- Beijing
- People
- 80
- Run by
- Peking University People's Hospital
See details and how to joinNCT07359040 - 1. fázisNot yet taking people in KínaStudy of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 198
- Run by
- Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
See details and how to joinNCT07624214 - 1. fázisTaking peopleA Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 502
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06936735 - 2/3. fázisTaking peopleA Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 706
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07459751 - 2. fázisTaking peopleThe Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 120
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07617246 - 3. fázisNot yet taking people in KínaSelective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer (SCIENCE Study)
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 358
- Run by
- Wen-zhao ZHONG
See details and how to joinNCT07617389 - 2. fázisNot yet taking people in KínaIntermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- zhang yi
See details and how to joinNCT07618793 - 2/3. fázisTaking peopleTrop2-targeted immunoPET Imaging of Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 400
- Run by
- RenJi Hospital
See details and how to joinNCT06851663 - No phaseTaking peopleSub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 585
- Run by
- Wen-zhao ZHONG
See details and how to joinNCT07612722 - No phaseTaking peopleClinical Application of PET Imaging Targeting MSLN in Malignant Tumors
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 100
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06843629 - No phaseTaking peopleStudy on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
- Where
- Guangzhou
- Életkor
- 18 év to 100 év
- People
- 10
- Run by
- Guangzhou Institute of Respiratory Disease
See details and how to joinNCT07610616